2020 Q2 Form 10-Q Financial Statement

#000087786020000091 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $84.17M $78.10M $76.11M
YoY Change 7.78% 7.05% 4.62%
Cost Of Revenue $1.450M $1.510M $1.090M
YoY Change -3.97%
Gross Profit $82.72M $76.59M $75.02M
YoY Change 8.0%
Gross Profit Margin 98.27% 98.07% 98.57%
Selling, General & Admin $3.430M $3.850M $4.830M
YoY Change -10.91% 18.46% 4.32%
% of Gross Profit 4.15% 5.03% 6.44%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $20.85M $19.02M $18.49M
YoY Change 9.61% 6.89% 6.67%
% of Gross Profit 25.2% 24.83% 24.65%
Operating Expenses $38.90M $38.12M $40.43M
YoY Change 2.05% 8.55% 20.41%
Operating Profit $43.82M $39.98M $35.68M
YoY Change 9.61% 5.65% -8.91%
Interest Expense $13.56M $13.75M $13.52M
YoY Change -1.37% 12.49% 16.39%
% of Operating Profit 30.94% 34.38% 37.89%
Other Income/Expense, Net
YoY Change
Pretax Income $44.43M $39.98M $35.68M
YoY Change 11.13% 5.66% -7.16%
Income Tax
% Of Pretax Income
Net Earnings $44.37M $39.98M $35.68M
YoY Change 10.98% 5.66% -7.16%
Net Earnings / Revenue 52.71% 51.19% 46.88%
Basic Earnings Per Share $0.99 $0.92 $0.83
Diluted Earnings Per Share $0.99 $0.92 $0.83
COMMON SHARES
Basic Shares Outstanding 44.65M shares 43.23M shares 42.83M shares
Diluted Shares Outstanding 44.65M shares 43.50M shares 43.13M shares

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $46.90M $5.600M $5.200M
YoY Change 737.5% 86.67% 62.5%
Cash & Equivalents $46.85M $5.635M $5.177M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $3.000M $2.900M
Other Receivables $78.60M $75.10M
Total Short-Term Assets $136.0M $87.20M $83.20M
YoY Change 55.96% -28.23% -27.15%
LONG-TERM ASSETS
Property, Plant & Equipment $2.691B $2.571B $2.435B
YoY Change 4.68% 7.64% 6.5%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $414.0K
YoY Change
Other Assets $18.60M $14.60M $14.10M
YoY Change 27.4% 180.77% 71.95%
Total Long-Term Assets $3.031B $2.910B $2.723B
YoY Change 4.15% 14.05% 11.36%
TOTAL ASSETS
Total Short-Term Assets $136.0M $87.20M $83.20M
Total Long-Term Assets $3.031B $2.910B $2.723B
Total Assets $3.167B $2.997B $2.806B
YoY Change 5.66% 12.13% 9.64%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $33.00M $25.90M $21.40M
YoY Change 27.41% 54.17% 29.7%
Accrued Expenses $1.200M $1.200M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $92.90M $83.30M $78.60M
YoY Change 11.52% 3.74% -0.88%
LONG-TERM LIABILITIES
Long-Term Debt $1.554B $1.472B $1.287B
YoY Change 5.6% 20.08% 10.95%
Other Long-Term Liabilities $16.40M $22.60M $24.60M
YoY Change -27.43% 289.66%
Total Long-Term Liabilities $1.571B $1.494B $1.312B
YoY Change 5.1% 21.35% 13.07%
TOTAL LIABILITIES
Total Short-Term Liabilities $92.90M $83.30M $78.60M
Total Long-Term Liabilities $1.571B $1.494B $1.312B
Total Liabilities $1.664B $1.578B $1.390B
YoY Change 5.44% 20.26% 12.16%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.506B $1.420B $1.407B
YoY Change 6.06% 6.4% 9.15%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.492B $1.419B $1.416B
YoY Change
Total Liabilities & Shareholders Equity $3.167B $2.997B $2.806B
YoY Change 5.66% 12.13% 9.64%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income $44.37M $39.98M $35.68M
YoY Change 10.98% 5.66% -7.16%
Depreciation, Depletion And Amortization $20.85M $19.02M $18.49M
YoY Change 9.61% 6.89% 6.67%
Cash From Operating Activities $59.70M $53.10M $73.84M
YoY Change 12.43% -0.38% 51.07%
INVESTING ACTIVITIES
Capital Expenditures -$14.30M -$150.5M -$50.10M
YoY Change -90.5% 30.64% 247.92%
Acquisitions
YoY Change
Other Investing Activities -$14.80M -$52.50M -$14.90M
YoY Change -71.81% 760.66% 186.54%
Cash From Investing Activities -$29.10M -$203.0M -$65.04M
YoY Change -85.67% 67.35% 232.07%
FINANCING ACTIVITIES
Cash Dividend Paid $42.70M
YoY Change 8.22%
Common Stock Issuance & Retirement, Net $35.91M
YoY Change -64230.36%
Debt Paid & Issued, Net $296.0K
YoY Change
Cash From Financing Activities -45.00M 150.9M -$3.156M
YoY Change -129.82% 122.24% -89.02%
NET CHANGE
Cash From Operating Activities 59.70M 53.10M $73.84M
Cash From Investing Activities -29.10M -203.0M -$65.04M
Cash From Financing Activities -45.00M 150.9M -$3.156M
Net Change In Cash -14.40M 1.000M $5.642M
YoY Change -1540.0% -1100.0% 952.61%
FREE CASH FLOW
Cash From Operating Activities $59.70M $53.10M $73.84M
Capital Expenditures -$14.30M -$150.5M -$50.10M
Free Cash Flow $74.00M $203.6M $123.9M
YoY Change -63.65% 20.83% 95.86%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
dei Entity Central Index Key
EntityCentralIndexKey
0000877860
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
60000000 shares
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44650002 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44587486 shares
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44650002 shares
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44587486 shares
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2019Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.05
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.05
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-10822
dei Entity Registrant Name
EntityRegistrantName
National Health Investors Inc
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MD
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
62-1470956
dei Entity Address Address Line1
EntityAddressAddressLine1
222 Robert Rose Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
Murfreesboro
dei Entity Address State Or Province
EntityAddressStateOrProvince
TN
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
37129
dei City Area Code
CityAreaCode
(615)
dei Local Phone Number
LocalPhoneNumber
890-9100
dei Security12b Title
Security12bTitle
Common Stock, $0.01 par value
dei Trading Symbol
TradingSymbol
NHI
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
44650002 shares
CY2020Q2 us-gaap Land
Land
219919000 USD
CY2019Q4 us-gaap Land
Land
213617000 USD
CY2020Q2 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
3025619000 USD
CY2019Q4 us-gaap Investment Building And Building Improvements
InvestmentBuildingAndBuildingImprovements
2836673000 USD
CY2020Q2 us-gaap Construction In Progress Gross
ConstructionInProgressGross
1600000 USD
CY2019Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
24556000 USD
CY2020Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3247138000 USD
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3074846000 USD
CY2020Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
555762000 USD
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
514453000 USD
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2691376000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2560393000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
300130000 USD
CY2019Q4 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
340143000 USD
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
46853000 USD
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5215000 USD
CY2020Q2 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
89090000 USD
CY2019Q4 us-gaap Deferred Rent Receivables Net
DeferredRentReceivablesNet
86044000 USD
CY2020Q2 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
0 USD
CY2019Q4 us-gaap Real Estate Heldforsale
RealEstateHeldforsale
18420000 USD
CY2020Q2 us-gaap Other Assets
OtherAssets
39522000 USD
CY2020Q2 us-gaap Other Assets
OtherAssets
39522000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
32020000 USD
CY2020Q2 us-gaap Assets
Assets
3166971000 USD
CY2019Q4 us-gaap Assets
Assets
3042235000 USD
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1554241000 USD
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1440465000 USD
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
33026000 USD
CY2019Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
26313000 USD
CY2020Q2 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
49226000 USD
CY2019Q4 us-gaap Dividends Payable Current And Noncurrent
DividendsPayableCurrentAndNoncurrent
46817000 USD
CY2020Q2 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2019Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
10638000 USD
CY2020Q2 us-gaap Deferred Revenue
DeferredRevenue
16371000 USD
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
19750000 USD
CY2020Q2 us-gaap Liabilities
Liabilities
1663502000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1543983000 USD
CY2020Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
447000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
446000 USD
CY2020Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1505265000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1505948000 USD
CY2020Q2 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-2618000 USD
CY2019Q4 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-5331000 USD
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-10735000 USD
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-3432000 USD
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
1492359000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1497631000 USD
CY2020Q2 us-gaap Minority Interest
MinorityInterest
11110000 USD
CY2019Q4 us-gaap Minority Interest
MinorityInterest
621000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1503469000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1498252000 USD
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3166971000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3042235000 USD
CY2020Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
77917000 USD
CY2019Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
72578000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
154444000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
143531000 USD
CY2020Q2 us-gaap Interest Income Operating
InterestIncomeOperating
6257000 USD
CY2019Q2 us-gaap Interest Income Operating
InterestIncomeOperating
5518000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
12827000 USD
us-gaap Interest Income Operating
InterestIncomeOperating
10673000 USD
CY2020Q2 us-gaap Revenues
Revenues
84174000 USD
CY2019Q2 us-gaap Revenues
Revenues
78096000 USD
us-gaap Revenues
Revenues
167271000 USD
us-gaap Revenues
Revenues
154204000 USD
CY2020Q2 us-gaap Depreciation
Depreciation
20847000 USD
CY2019Q2 us-gaap Depreciation
Depreciation
19020000 USD
us-gaap Depreciation
Depreciation
41290000 USD
us-gaap Depreciation
Depreciation
37511000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
13557000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
13746000 USD
us-gaap Interest Expense
InterestExpense
27697000 USD
us-gaap Interest Expense
InterestExpense
27264000 USD
CY2020Q2 us-gaap Legal Fees
LegalFees
250000 USD
CY2019Q2 us-gaap Legal Fees
LegalFees
99000 USD
us-gaap Legal Fees
LegalFees
585000 USD
us-gaap Legal Fees
LegalFees
369000 USD
CY2020Q2 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
145000 USD
CY2019Q2 nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
775000 USD
nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
389000 USD
nhi Franchise Excise And Other Taxes
FranchiseExciseAndOtherTaxes
1320000 USD
CY2020Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3032000 USD
CY2019Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2972000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
7342000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
6986000 USD
CY2020Q2 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
1450000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
CY2019Q2 nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
1506000 USD
nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
3002000 USD
nhi Lessor Property Costs Paid From Tenant Escrow
LessorPropertyCostsPaidFromTenantEscrow
2597000 USD
CY2020Q2 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
-380000 USD
CY2019Q2 nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
0 USD
nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1195000 USD
nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
2500000 USD
CY2020Q2 us-gaap Operating Expenses
OperatingExpenses
38901000 USD
CY2019Q2 us-gaap Operating Expenses
OperatingExpenses
38118000 USD
us-gaap Operating Expenses
OperatingExpenses
81500000 USD
us-gaap Operating Expenses
OperatingExpenses
78547000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-848000 USD
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1290000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
CY2020Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2019Q2 us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
44425000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
39978000 USD
us-gaap Profit Loss
ProfitLoss
105488000 USD
us-gaap Profit Loss
ProfitLoss
75657000 USD
CY2020Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
57000 USD
CY2019Q2 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
96000 USD
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
44368000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39979000 USD
us-gaap Net Income Loss
NetIncomeLoss
105392000 USD
us-gaap Net Income Loss
NetIncomeLoss
75658000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44650002 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43232384 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44631797 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43311527 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43029104 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44650002 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43498021 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44634070 shares
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.76
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.36
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.75
CY2020Q2 us-gaap Profit Loss
ProfitLoss
44425000 USD
CY2019Q2 us-gaap Profit Loss
ProfitLoss
39978000 USD
us-gaap Profit Loss
ProfitLoss
105488000 USD
us-gaap Profit Loss
ProfitLoss
75657000 USD
CY2020Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-867000 USD
CY2019Q2 us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-3451000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-10058000 USD
us-gaap Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax
-4117000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-2263000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
350000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
-2755000 USD
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci On Derivatives Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIOnDerivativesNetOfTax
641000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
1396000 USD
CY2019Q2 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-3801000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7303000 USD
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-4758000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
45821000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36177000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
98185000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
70899000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
57000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
96000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-1000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
45764000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
36178000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
98089000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
70900000 USD
us-gaap Profit Loss
ProfitLoss
105488000 USD
us-gaap Profit Loss
ProfitLoss
75657000 USD
us-gaap Depreciation
Depreciation
41290000 USD
us-gaap Depreciation
Depreciation
37511000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2350000 USD
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2551000 USD
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
435000 USD
us-gaap Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
241000 USD
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
485000 USD
us-gaap Amortization Of Lease Incentives
AmortizationOfLeaseIncentives
383000 USD
us-gaap Straight Line Rent
StraightLineRent
10395000 USD
us-gaap Straight Line Rent
StraightLineRent
10535000 USD
us-gaap Other Noncash Income
OtherNoncashIncome
1844000 USD
us-gaap Other Noncash Income
OtherNoncashIncome
1005000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
21007000 USD
us-gaap Gains Losses On Sales Of Investment Real Estate
GainsLossesOnSalesOfInvestmentRealEstate
0 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1290000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0 USD
nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
1195000 USD
nhi Loanand Lease Lossesand Recoveries Net
LoanandLeaseLossesandRecoveriesNet
2500000 USD
nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
0 USD
nhi Paymentof Tenant Lease Incentives
PaymentofTenantLeaseIncentives
-2600000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2315000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2478000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
742000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2474000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-3318000 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
1571000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
137000 USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
16170000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
116809000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
126914000 USD
us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
32826000 USD
us-gaap Payments To Acquire Mortgage Notes Receivable
PaymentsToAcquireMortgageNotesReceivable
59655000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
14579000 USD
us-gaap Proceeds From Sale And Collection Of Mortgage Notes Receivable
ProceedsFromSaleAndCollectionOfMortgageNotesReceivable
558000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
94630000 USD
us-gaap Payments To Acquire Real Estate
PaymentsToAcquireRealEstate
200632000 USD
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
54000 USD
us-gaap Payments To Develop Real Estate Assets
PaymentsToDevelopRealEstateAssets
0 USD
nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
5579000 USD
nhi Payments To Renovate Real Estate
PaymentsToRenovateRealEstate
8300000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
875000 USD
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
0 USD
us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
0 USD
us-gaap Proceeds From Sale Of Wholly Owned Real Estate And Real Estate Acquired In Settlement Of Loans
ProceedsFromSaleOfWhollyOwnedRealEstateAndRealEstateAcquiredInSettlementOfLoans
39260000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80125000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-268029000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
145000000 USD
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
292000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
32000000 USD
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
103000000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
609000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
589000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
90000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
298000 USD
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
0 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
13000 USD
us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
642000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
1016000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
47854000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
293000 USD
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
0 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
96043000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
88060000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13065000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
147741000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
49749000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
6626000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15669000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
9912000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65418000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16538000 USD
us-gaap Interest Paid Net
InterestPaidNet
23533000 USD
us-gaap Interest Paid Net
InterestPaidNet
26032000 USD
nhi Changein Straightline Rent Receivable Investmentsin Real Estate
ChangeinStraightlineRentReceivableInvestmentsinRealEstate
0 USD
nhi Changein Straightline Rent Receivable Investmentsin Real Estate
ChangeinStraightlineRentReceivableInvestmentsinRealEstate
38000000 USD
nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
59350000 USD
nhi Additions Through Settlement Of Mortgage Note
AdditionsThroughSettlementOfMortgageNote
0 USD
nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
4000000 USD
nhi Increase In Mortgage Note Receivable From Sale Of Real Estate
IncreaseInMortgageNoteReceivableFromSaleOfRealEstate
0 USD
nhi Changein Other Assets Investmentsin Real Estate
ChangeinOtherAssetsInvestmentsinRealEstate
0 USD
nhi Changein Other Assets Investmentsin Real Estate
ChangeinOtherAssetsInvestmentsinRealEstate
176000 USD
nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
1899000 USD
nhi Changein Accounts Payable Investmentsin Real Estate Construction
ChangeinAccountsPayableInvestmentsinRealEstateConstruction
-1981000 USD
nhi Changein Accounts Payable Investmentsin Real Estate Acquisition
ChangeinAccountsPayableInvestmentsinRealEstateAcquisition
0 USD
nhi Changein Accounts Payable Investmentsin Real Estate Acquisition
ChangeinAccountsPayableInvestmentsinRealEstateAcquisition
1178000 USD
nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
100000 USD
nhi Change In Accounts Payable Related To Distributions To Noncontrolling Interests
ChangeInAccountsPayableRelatedToDistributionsToNoncontrollingInterests
0 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1498252000 USD
CY2020Q1 us-gaap Noncontrolling Interest Increase From Subsidiary Equity Issuance
NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance
10791000 USD
CY2020Q1 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
16000 USD
CY2020Q2 us-gaap Number Of Real Estate Properties
NumberOfRealEstateProperties
227 properties
CY2020Q2 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
34
CY2020Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
52363000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
85000 USD
CY2020Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2705000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
1845000 USD
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49226000 USD
CY2020Q2 us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
382000 USD
CY2020Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
45821000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
206000 USD
CY2020Q2 us-gaap Share Based Compensation
ShareBasedCompensation
470000 USD
CY2020Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
49227000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1503469000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1389713000 USD
CY2019Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
34722000 USD
CY2019Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
462925 shares
CY2019Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
35913000 USD
CY2019Q1 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1006000 USD
CY2019Q1 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
35982 shares
CY2019Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 USD
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2001000 USD
CY2019Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45359000 USD
CY2019Q2 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
36177000 USD
CY2019Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
11942000 USD
CY2019Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
10000 USD
CY2019Q2 us-gaap Share Based Compensation
ShareBasedCompensation
477000 USD
CY2019Q2 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
45525000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1419686000 USD
CY2020Q2 nhi Real Estate Investment Property Portfolio Assets
RealEstateInvestmentPropertyPortfolioAssets
3244562000 USD
CY2020Q2 nhi Nonportfolio Assets Original Cost
NonportfolioAssetsOriginalCost
2575000 USD
CY2020Q2 nhi Number Of Lessees
NumberOfLessees
34
CY2020Q2 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
16 beds_or_units
CY2020Q2 us-gaap Loans And Leases Receivable Gross Carrying Amount
LoansAndLeasesReceivableGrossCarryingAmount
305319000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5189000 USD
CY2020Q2 nhi Variable Interest Entity Number Of Entities Not Primary Beneficiary
VariableInterestEntityNumberOfEntitiesNotPrimaryBeneficiary
8 properties
CY2020Q2 us-gaap Cash
Cash
46853000 USD
CY2019Q2 us-gaap Cash
Cash
5635000 USD
CY2020Q2 us-gaap Restricted Cash
RestrictedCash
18565000 USD
CY2019Q2 us-gaap Restricted Cash
RestrictedCash
10903000 USD
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
65418000 USD
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
16538000 USD
CY2020Q2 nhi Lease Escalator Minimum
LeaseEscalatorMinimum
0.0225
CY2020Q2 nhi Lease Escalator Minimum
LeaseEscalatorMinimum
0.0225
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5189000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Remainder Of Fiscal Year
OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear
141225000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
281081000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
285478000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
281615000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
274075000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
267462000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
1394428000 USD
CY2020Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
2925364000 USD
CY2020Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
77917000 USD
CY2019Q2 us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
72578000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
154444000 USD
us-gaap Operating Leases Income Statement Lease Revenue
OperatingLeasesIncomeStatementLeaseRevenue
143531000 USD
CY2020Q2 nhi Number Of Health Care Properties Related To Mortgage Notes Receivables
NumberOfHealthCarePropertiesRelatedToMortgageNotesReceivables
16 properties
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
300130000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5189000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5189000 USD
CY2020Q2 us-gaap Loans And Leases Receivable Net Reported Amount
LoansAndLeasesReceivableNetReportedAmount
300130000 USD
CY2020Q2 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2020Q2 nhi Probability Of Default Increase Current Conditions Adjustment
ProbabilityOfDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2020Q2 nhi Loss Given Default Increase Current Conditions Adjustment
LossGivenDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2020Q2 nhi Loss Given Default Increase Current Conditions Adjustment
LossGivenDefaultIncreaseCurrentConditionsAdjustment
0.20
CY2020Q2 nhi Estimated Credit Losses Current Conditions Adjustment Combined
EstimatedCreditLossesCurrentConditionsAdjustmentCombined
0.44
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
1289000 USD
CY2020Q2 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
5189000 USD
CY2020Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
20063000 USD
CY2020Q1 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
20063000 USD
CY2020Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
17530000 USD
CY2020Q2 us-gaap Guarantee Obligations Maximum Exposure
GuaranteeObligationsMaximumExposure
17530000 USD
CY2020Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-848000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-1290000 USD
CY2020Q2 us-gaap Equity Method Investments
EquityMethodInvestments
414000 USD
CY2020Q2 us-gaap Line Of Credit
LineOfCredit
413000000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
300000000 USD
CY2020Q2 us-gaap Convertible Debt
ConvertibleDebt
59898000 USD
CY2019Q4 us-gaap Convertible Debt
ConvertibleDebt
59697000 USD
CY2020Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5932000 USD
CY2019Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
7076000 USD
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1554241000 USD
CY2019Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1440465000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year
LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear
621000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Rolling Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextRollingTwelveMonths
61279000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFour
76429000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearFive
144800000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingYearTwo
664328000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
476378000 USD
CY2020Q2 us-gaap Long Term Debt Maturities Repayments Of Principal In Rolling After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInRollingAfterYearFive
137638000 USD
CY2020Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
1561473000 USD
CY2020Q2 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
1300000 USD
CY2020Q2 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
5932000 USD
CY2020Q2 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1554241000 USD
CY2020Q2 nhi Credit Facility Current Revolving Borrowing Capacity
CreditFacilityCurrentRevolvingBorrowingCapacity
550000000 USD
CY2020Q2 nhi Credit Facility Current Revolving Borrowing Capacity
CreditFacilityCurrentRevolvingBorrowingCapacity
550000000 USD
us-gaap Line Of Credit Facility Unused Capacity Commitment Fee Percentage
LineOfCreditFacilityUnusedCapacityCommitmentFeePercentage
20
CY2020Q2 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
16
CY2019Q4 nhi Debt Instrument Variable Rate Basis Minimum
DebtInstrumentVariableRateBasisMinimum
176
CY2020Q2 us-gaap Unsecured Debt
UnsecuredDebt
400000000 USD
nhi Debt Leverage Limit Coupon Change Trigger
DebtLeverageLimitCouponChangeTrigger
0.50
us-gaap Debt Instrument Convertible Conversion Ratio1
DebtInstrumentConvertibleConversionRatio1
14.80
CY2020Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
67.58
us-gaap Debt Instrument Convertible Number Of Equity Instruments
DebtInstrumentConvertibleNumberOfEquityInstruments
887856 shares
CY2020Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
67.58
CY2020Q2 us-gaap Interest Rate Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Net
InterestRateCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsNet
7094000 USD
CY2019Q4 us-gaap Derivative Fair Value Of Derivative Net
DerivativeFairValueOfDerivativeNet
-3434000 USD
CY2020Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
10569000 USD
CY2019Q2 us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
13355000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
23572000 USD
us-gaap Interest Expense Debt Excluding Amortization
InterestExpenseDebtExcludingAmortization
26429000 USD
CY2020Q2 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
2263000 USD
CY2019Q2 us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
350000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
2755000 USD
us-gaap Derivative Instruments Loss Reclassified From Accumulated Oci Into Income Effective Portion
DerivativeInstrumentsLossReclassifiedFromAccumulatedOCIIntoIncomeEffectivePortion
641000 USD
CY2020Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
19000 USD
CY2019Q2 us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
158000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
117000 USD
us-gaap Interest Costs Capitalized Adjustment
InterestCostsCapitalizedAdjustment
315000 USD
CY2020Q2 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
744000 USD
CY2019Q2 nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
899000 USD
nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
1487000 USD
nhi Amortization Of Financing Costs Exclusive Of Amounts Written Off
AmortizationOfFinancingCostsExclusiveOfAmountsWrittenOff
1791000 USD
CY2020Q2 us-gaap Interest Expense
InterestExpense
13557000 USD
CY2019Q2 us-gaap Interest Expense
InterestExpense
13746000 USD
us-gaap Interest Expense
InterestExpense
27697000 USD
CY2020Q2 nhi Contingent Funding Commitment
ContingentFundingCommitment
31850000 USD
us-gaap Interest Expense
InterestExpense
27264000 USD
us-gaap Loans And Leases Receivable Commitments Fixed Rates
LoansAndLeasesReceivableCommitmentsFixedRates
256450000 USD
CY2020Q2 nhi Notes Receivable Funding Commitment
NotesReceivableFundingCommitment
63993000 USD
us-gaap Off Balance Sheet Credit Loss Liability Credit Loss Expense Reversal
OffBalanceSheetCreditLossLiabilityCreditLossExpenseReversal
-94000 USD
CY2020Q2 us-gaap Off Balance Sheet Credit Loss Liability
OffBalanceSheetCreditLossLiability
231000 USD
CY2020Q2 nhi Maximum Commitment For All Active Development Projects
MaximumCommitmentForAllActiveDevelopmentProjects
46645000 USD
CY2020Q2 us-gaap Development In Process
DevelopmentInProcess
41706000 USD
CY2020Q2 nhi Remaining Unfunded Development Commitment
RemainingUnfundedDevelopmentCommitment
4939000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
618654 shares
CY2020Q2 nhi At The Market Shelf Registration Equity Offering Sales Agreement Aggregate Sales Price
AtTheMarketShelfRegistrationEquityOfferingSalesAgreementAggregateSalesPrice
500000000 USD
us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
0 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
2730169 shares
CY2020Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
470000 USD
CY2019Q2 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
477000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2315000 USD
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
2478000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
5.57
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.17
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.051
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.055
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.171
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.186
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0130
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0250
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
920346 shares
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
69.24
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
79.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
71.14
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1154516 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.26
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
663997 shares
CY2019Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
73.64
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1004014 shares
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
74.35
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
592000 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
90.32
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
512509 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
72.98
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
10500 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
88.73
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1073005 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
83.68
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y11M12D
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
601994 shares
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
81.09
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y7M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
8118000 USD
nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
15.84
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4100000 USD
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4100000 USD
nhi Aggregate Intrinsic Value Per Share Options Exercised
AggregateIntrinsicValuePerShareOptionsExercised
11.00
CY2020Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
1703000 USD
CY2020Q2 us-gaap Net Income Loss
NetIncomeLoss
44368000 USD
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
39979000 USD
us-gaap Net Income Loss
NetIncomeLoss
105392000 USD
us-gaap Net Income Loss
NetIncomeLoss
75658000 USD
CY2020Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44650002 shares
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43232384 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
44631797 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43029104 shares
CY2020Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44650002 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.36
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.76
CY2019Q2 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
43232384 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
44631797 shares
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
43029104 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
0 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
66145 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2273 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
70920 shares
CY2020Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
CY2019Q2 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
199492 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
0 shares
us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
211503 shares
CY2020Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44650002 shares
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43498021 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44634070 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
43311527 shares
CY2020Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.99
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.75
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
610367 shares
CY2020Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.99
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.92
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.36
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
40173 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
439962 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
21227 shares
CY2020Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.1025
CY2019Q2 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.05
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.205
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
2.10

Files In Submission

Name View Source Status
0000877860-20-000091-index-headers.html Edgar Link pending
0000877860-20-000091-index.html Edgar Link pending
0000877860-20-000091.txt Edgar Link pending
0000877860-20-000091-xbrl.zip Edgar Link pending
amendmenttoarticlesofi.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nhi-20200630.htm Edgar Link pending
nhi-20200630.xsd Edgar Link pending
nhi-20200630_cal.xml Edgar Link unprocessable
nhi-20200630_def.xml Edgar Link unprocessable
nhi-20200630_htm.xml Edgar Link completed
nhi-20200630_lab.xml Edgar Link unprocessable
nhi-20200630_pre.xml Edgar Link unprocessable
nhi-6302020x10qex311.htm Edgar Link pending
nhi-6302020x10qex312.htm Edgar Link pending
nhi-6302020x10qex32.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
R9999.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending